Building Momentum: Accelerating Swansea’s Spin-outs

Swansea University continues to strengthen its reputation as a powerhouse of innovation, now ranked 4th in the UK for spin-out company creation. This achievement reflects a vibrant ecosystem where cutting-edge research is translated into real-world impact, driving economic growth and societal benefit in Wales, the UK and beyond.

Swansea’s growing portfolio of spin-out successes highlights the ambition and diversity of its entrepreneurial community. Ventures such as CanSense are advancing early cancer detection technologies, while Ail Arian is enabling more sustainable electronics recycling, showing how research 
tackles pressing global challenges. Grove Nanomaterials is innovating in advanced materials for allergy testing, as Viamab and Corryn Biotechnologies drive progress in life-saving treatments. Beyond science, VoxPol addresses online extremism and the Children’s Legal Centre Wales supports young people, 
making a meaningful difference across communities today.

These ventures embody Swansea’s commitment to nurturing and transforming
a strong pipeline of ideas from lab to marketplace.

As this momentum builds, Swansea University invites its global alumni network to play an active role. From mentoring founders and unlocking networks, to investing and influencing board-level strategy, 
entrepreneurial alumni can accelerate ventures already gaining traction—helping scale the next generation of spin-outs and sustaining Swansea’s position at the forefront of innovation.
For those looking to deploy capital, insight and experience where it matters most, this is an opportunity to work alongside Swansea’s commercialisation team at a pivotal stage—shaping ventures that are tackling global challenges today.

To explore this further,  contact giving@swansea.ac.uk 

CANSENSE

Co-founded by Professor Peter Dunstan at Swansea University, CanSense’s pioneering blood test uses spectroscopy and AI to tackle one of the world’s deadliest cancers, accelerating patients’ diagnosis and reducing the growing global burden of bowel cancer.

Find out more at cansenseltd.com

CanSense